<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03269942</url>
  </required_header>
  <id_info>
    <org_study_id>SCAT</org_study_id>
    <nct_id>NCT03269942</nct_id>
  </id_info>
  <brief_title>Study of Complex Intracranial Aneurysm Treatment</brief_title>
  <acronym>SCAT</acronym>
  <official_title>Results of Revascularization Versus Endovascular Flow Diversion in Treatment of Complex Intracranial Aneurysms of Anterior Circulation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Meshalkin Research Institute of Pathology of Circulation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Meshalkin Research Institute of Pathology of Circulation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigator expects that endovascular flow-diversion is superior over revascularization
      by postoperative modified Rankin scale (mRS) in patients with complex intracranial aneurysms.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Open, prospective, controlled randomized superiority trial is conducted. The hypothesis is
      that endovascular flow-diversion is better than revascularization in treatment of complex
      intracranial aneurysms by postoperative modified Rankin Scale (mRS). Sample size was measured
      by Fisher exact test. Depending on a type of the procedure, the patients are divided into two
      groups: Endovascular Flow Diversion Procedure (include 55 patients) and Revascularization
      Procedure (include 55 patients). Randomization is performed by random number generation.The
      study was approved by Institutional Review Board
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">March 14, 2015</start_date>
  <completion_date type="Anticipated">June 1, 2018</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>mRS</measure>
    <time_frame>6, 12 months after procedure</time_frame>
    <description>Change from baseline modified Rankin Scale</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Complete aneurysm occlusion</measure>
    <time_frame>6, 12 months after procedure</time_frame>
    <description>Measured as: complete occlusion or residual aneurysm (included neck remnant)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Major stroke (ischemic or hemorrhagic) or neurological death related to the treatment of the target aneurysm</measure>
    <time_frame>6, 12 months after procedure</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">110</enrollment>
  <condition>Intracranial Aneurysm</condition>
  <arm_group>
    <arm_group_label>Endovascular Flow-Diversion</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Implantation of flow-diversion device</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cerebral Revascularization</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Cerebral revascularization procedure with trapping of aneurysm</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Endovascular Flow-Diversion</intervention_name>
    <description>Implantation of flow-diverter in treatment of complex aneurysms of anterior circulation.</description>
    <arm_group_label>Endovascular Flow-Diversion</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Cerebral Revascularization</intervention_name>
    <description>Cerebral revascularization with trapping of aneurysm in treatment of complex aneurysms of anterior circulation.</description>
    <arm_group_label>Cerebral Revascularization</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  anterior circulation complex intracranial aneurysm

          -  neck is more than 4 mm wide

          -  dome/neck ratio of aneurysm equals or less than 2:1

          -  age less than 75 years

          -  ability to give informed consent (subject or legally authorized representative)

          -  aneurysm is suitable for treatment to both procedures

        Exclusion Criteria:

          -  subarachnoid hemorrhage less than 30 days ago

          -  contraindications to endovascular treatment

          -  atypical aneurysms (mycotic, flow-related in patients with AVM, traumatic, false)

          -  informed consent refusal
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Novosibirsk Research Institution of Circulation Pathology</name>
      <address>
        <city>Novosibirsk</city>
        <zip>630055</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Russian Federation</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 29, 2017</study_first_submitted>
  <study_first_submitted_qc>August 30, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">September 1, 2017</study_first_posted>
  <last_update_submitted>August 30, 2017</last_update_submitted>
  <last_update_submitted_qc>August 30, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 1, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Intracranial Aneurysm</keyword>
  <keyword>Flow Diverter</keyword>
  <keyword>Cerebral Revascularization</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Intracranial Aneurysm</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

